Analyst Ratings for Nabriva Therapeutics AG (NBRV) [Buys]
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.6 / 10 Percentile Rank: 34%
Rating Score: 3.6 / 10 Percentile Rank: 34%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/21/2018 | BofA Securities » Updated 8/20/2019 |
Jason Gerberry | New Coverage | Buy (N/A) |
6.00 (5.00) |
5.39 (1.42) |
-73.65% | Details |
6/23/2017 | Cantor Fitzgerald » Updated 5/21/2018 |
N/A | New Coverage | Overweight (N/A) |
16.00 (N/A) |
9.31 (1.42) |
-84.75% | Details |